United States · Platforms & data · Seeking Alpha

Pfizer raises 2026 outlook to $62B-$64B revenue and $2.95-$3.05 adjusted EPS, targeting high single-digit revenue CAGR from 2028-2033

Published by Seeking Alpha · United States 2 h ago

Read the full article on Seeking Alpha Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (seekingalpha.com)

Also worth reading

Broadcom Inc. $AVGO Stock Sold by Americana Partners LLC

The Motley Fool

Zcash Is Getting a Major Upgrade in November. Could This Be a Catalyst for Further ZEC Price Gains?

Treasury yields fall as investors crowd into bonds for safety amid election stock sell-off

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Market News

HC Wainwright & Co. upgrades Inovio Pharmaceuticals to Buy from Neutral, sets price target at $5